LB PHARMACEUTICALS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 |
|---|---|---|---|
| Income Statement | |||
| Net income | -$25.2 | -$63.1 | — |
| Cash Flow Statement | |||
| Free cash flow | -$35.3 | -$53.8 | — |
Shares outstanding 32.3M · Free float 79.4%
Annual filing data through FY ended December 31, 2025; float as of October 3, 2026.